Skip to main content
Celon Pharma S.A. logo

Celon Pharma S.A. — Investor Relations & Filings

Ticker · CLN ISIN · PLCLNPH00015 LEI · 259400Q0ERJT0NC5DT24 WAR Manufacturing
Open in API
Filings indexed 709 across all filing types
Latest filing 2019-04-23 Report Publication Anno…
Country PL Poland
Listing WAR CLN

About Celon Pharma S.A.

https://celonpharma.com/en/

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Recent filings

Filing Released Lang Actions
Uzupełnienie dokumentacji na Zwyczajne Walne Zgromadzenie Celon Pharma S.A. zwołane na dzień 23 kwietnia 2019 roku - Content (PL)
Report Publication Announcement Classification · 98% confidence The document is a brief announcement (448 characters) in Polish. It explicitly states that it is a supplement ('W uzupełnieniu') to a previous current report regarding the Annual General Meeting (AGM) scheduled for April 23, 2019. The core purpose of this text is to inform recipients that the Supervisory Board's Report for 2018 ('Sprawozdanie Rady Nadzorczej Spółki za rok 2018') is attached for consideration at the AGM. According to Rule 2 (The 'MENU VS MEAL' Rule), a short document announcing that a report is attached or published should be classified as a Report Publication Announcement (RPA). Although the content relates to the AGM, the document itself is the announcement of the attached report, not the AGM materials (AGM-R) or the full annual report (10-K).
2019-04-23 Polish
Projekty Uchwał na ZWZ 23.04.2019
AGM Information Classification · 99% confidence The document text is titled 'PROJEKTY UCHWAŁ NA ZWYCZAJNE WALNE ZGROMADZENIE' (Draft Resolutions for the Annual General Meeting) and contains multiple numbered resolutions ('Uchwała nr X') dated April 23, 2019. These resolutions cover procedural matters (electing a chairman, adopting the agenda), reviewing and approving the 2018 Annual Report and Financial Statements, deciding on profit distribution (including dividends), and crucially, granting 'absolutorium' (discharge/vote of confidence) to members of the Management Board and Supervisory Board for their duties in 2018. The core content directly relates to the proceedings and decisions made at an Annual General Meeting (AGM). Therefore, the most appropriate classification is AGM Information (AGM-R).
2019-03-25 Polish
Ogłoszenie o zwołaniu ZWZ Celon Pharma S.A.
AGM Information Classification · 99% confidence The document title is "OGŁOSZENIE ZARZĄDU CELON PHARMA SPÓŁKA AKCYJNA O ZWOŁANIU ZWYCZAJNEGO WALNEGO ZGROMADZENIA" which translates to "ANNOUNCEMENT OF THE MANAGEMENT BOARD OF CELON PHARMA S.A. ON CONVENING THE ANNUAL GENERAL MEETING". The text details the date, time, location, and proposed agenda for the General Meeting (Walne Zgromadzenie), including items related to reviewing the 2018 annual report and granting discharge (absolutorium). This content directly relates to the formal process and materials surrounding the Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2019-03-25 Polish
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia Celon Pharma S.A. na dzień 23 kwietnia 2019 roku wraz z projektami uchwał - Content (PL)
AGM Information Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') is convening an Ordinary General Meeting ('Zwyczajne Walne Zgromadzenie') for April 23, 2019. The text details the planned agenda ('Planowany porządek obrad'), which includes reviewing the 2018 annual reports, financial statements, and profit distribution proposals. This content directly relates to the formal meeting of shareholders, which falls under the definition of AGM Information (AGM-R). Although it is a notice of the meeting, the detailed agenda covering annual review items makes it more specific than a general Report Publication Announcement (RPA).
2019-03-25 Polish
Odwołanie Zwyczajnego Walnego Zgromadzenia Celon Pharma S.A. zwołanego na dzień 18 kwietnia 2019 r. - Content (PL)
AGM Information Classification · 95% confidence The document text explicitly states that the Management Board ('Zarząd') of Celon Pharma S.A. is announcing the cancellation ('odwołaniu') of the Annual General Meeting ('Zwyczajnego Walnego Zgromadzenia') originally scheduled for April 18, 2019. It further states that a new AGM will be convened today and announced in a separate current report. This content relates directly to the scheduling and formal proceedings of the Annual General Meeting, fitting the description for AGM Information (AGM-R). Although it is an announcement about the meeting status rather than the meeting materials themselves, AGM-R is the most specific category available for AGM-related procedural announcements.
2019-03-25 Polish
notyfikacja_AW.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details the acquisition ('Nabycie') of shares ('Akcje') by a member of the Supervisory Board ('Członek Rady Nadzorczej') of Celon Pharma S.A. Article 19 of the MAR (Market Abuse Regulation) mandates reporting of transactions conducted by persons discharging managerial responsibilities (PDMRs). This directly corresponds to the definition of Director's Dealing (insider trades by directors/executives). The filing type code for this is DIRS.
2019-03-25 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.